Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
T. Rowe Price
TROW
$22.4B
| $468M | 0.02% |
4,116,868
+239,438
| +6% | +$24.5M |
2013 Q2
52 quarters
|
|
602
American Water Works
AWK
$25.6B
| $468M | 0.02% |
3,554,650
-57,747
| -2% | -$7.42M |
2013 Q2
52 quarters
|
|
603
State Street SPDR S&P Bank ETF
KBE
$1.48B
| $467M | 0.02% |
6,846,216
+5,466,662
| +396% | +$350M |
2013 Q2
52 quarters
|
|
604
RPM International
RPM
$12.5B
| $466M | 0.02% |
4,196,945
-329,423
| -7% | -$34.4M |
2013 Q2
52 quarters
|
|
605
Northern Trust
NTRS
$30.8B
| $466M | 0.02% |
2,678,749
+150,960
| +6% | +$24.9M |
2013 Q2
52 quarters
|
|
606
Emcor
EME
$34.8B
| $465M | 0.02% |
560,165
+30,877
| +6% | +$26.1M |
2013 Q2
52 quarters
|
|
607
Procore
PCOR
$8.54B
| $464M | 0.02% |
11,417,627
+2,336,625
| +26% | +$116M |
2021 Q2
20 quarters
|
|
608
Vanguard Health Care ETF
VHT
$19.3B
| $464M | 0.02% |
1,550,340
-22,941
| -1% | -$6.38M |
2013 Q2
52 quarters
|
|
609
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $462M | 0.02% |
8,818,356
-128,580
| -1% | -$6.74M |
2013 Q2
52 quarters
|
|
610
Rio Tinto
RIO
$154B
| $461M | 0.02% |
4,853,229
-36,145
| -0.7% | -$3.66M |
2013 Q2
52 quarters
|
|
611
Expedia Group
EXPE
$32.9B
| $459M | 0.02% |
1,795,471
-215,934
| -11% | -$51.3M |
2013 Q2
52 quarters
|
|
612
TransUnion
TRU
$12.5B
| $458M | 0.02% |
6,352,440
-577,413
| -8% | -$40.5M |
2015 Q2
44 quarters
|
|
613
Jones Lang LaSalle
JLL
$13.8B
| $457M | 0.02% |
1,475,893
-188,793
| -11% | -$58.7M |
2013 Q2
52 quarters
|
|
614
Sanofi
SNY
$96B
| $457M | 0.02% |
10,702,527
-1,809,340
| -14% | -$80.8M |
2013 Q2
52 quarters
|
|
615
LyondellBasell Industries
LYB
$19.4B
| $455M | 0.02% |
8,648,430
+1,979,697
| +30% | +$137M |
2013 Q2
52 quarters
|
|
616
Copart
CPRT
$25.3B
| $453M | 0.02% |
16,070,099
+1,579,868
| +11% | +$51M |
2013 Q2
52 quarters
|
|
617
Roper Technologies
ROP
$36B
| $452M | 0.02% |
1,335,843
-251,514
| -16% | -$85.8M |
2013 Q2
52 quarters
|
|
618
Eaton Vance Short Duration Income ETF
EVSD
$1.54B
| $452M | 0.02% |
8,881,070
+949,344
| +12% | +$48.4M |
2024 Q2
8 quarters
|
|
619
Garmin
GRMN
$51.8B
| $451M | 0.02% |
1,899,056
+121,311
| +7% | +$29.5M |
2013 Q2
52 quarters
|
|
620
Labcorp
LH
$25.3B
| $451M | 0.02% |
1,609,447
+111,420
| +7% | +$29.3M |
2013 Q2
52 quarters
|
|
621
Bio-Techne
TECH
$11.4B
| $450M | 0.02% |
6,374,717
-2,158,156
| -25% | -$117M |
2013 Q2
52 quarters
|
|
622
Dollar General
DG
$28.1B
| $450M | 0.02% |
3,907,161
-413,226
| -10% | -$47M |
2013 Q2
52 quarters
|
|
623
Rocket Companies
RKT
$32.5B
| $450M | 0.02% |
28,542,001
+5,948,345
| +26% | +$85.8M |
2020 Q3
23 quarters
|
|
624
iShares MSCI Emerging Markets ex China ETF
EMXC
$25.5B
| $449M | 0.02% |
4,391,922
+48,415
| +1% | +$4.57M |
2019 Q4
26 quarters
|
|
625
Interactive Brokers
IBKR
$39.8B
| $448M | 0.02% |
5,146,242
+380,670
| +8% | +$31.7M |
2013 Q2
52 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.